Publications

Nature biomedical engineering

Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma.

01-06-2025

ESMO real world data and digital oncology

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development.

01-06-2025

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.

01-06-2025

Contemporary clinical trials communications

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).

01-06-2025

NAR genomics and bioinformatics

Detecting ribosome collisions with differential rRNA fragment analysis in ribosome profiling data.

01-06-2025

Cancer reports (Hoboken, N.J.)

Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient-A Case Report.

01-06-2025

European journal of epidemiology

Cancer risk after in utero exposure to diethylstilbestrol.

01-06-2025

Biomedical chromatography : BMC

Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues.

01-06-2025

JCO oncology practice

General Practitioners' Experiences With Implementing Colon or Prostate Cancer Survivorship Care in Primary Care: A Cross-Sectional Survey Nested Within Two Randomized-Controlled Trials.

01-06-2025

Journal of the National Cancer Center

Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype.

01-06-2025

Trends in cancer

Myeloid cell path to malignancy: insights into liver cancer.

01-06-2025

EBioMedicine

Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.

01-06-2025

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.

01-06-2025

Maturitas

No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO).

01-06-2025

European radiology

Muscle atrophy and organ enlargement associated with quality of life during systemic therapy for melanoma: findings from an AI-based body composition analysis.

01-06-2025

The Lancet. Oncology

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

01-06-2025

Gastroenterology

Reply.

01-06-2025

Nature cancer

The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

01-06-2025

ESMO open

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma.

01-06-2025

Breast (Edinburgh, Scotland)

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.

01-06-2025

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.

01-06-2025

Oncology and therapy

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

01-06-2025

Molecular oncology

Strategies to reduce the cancer burden and improve access to effective and affordable cancer interventions in Europe.

01-06-2025

Journal of cancer survivorship : research and practice

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.

01-06-2025

Journal of the National Cancer Institute

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

01-06-2025

The British journal of surgery

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

31-05-2025

NPJ breast cancer

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study.

29-05-2025

Journal of cancer survivorship : research and practice

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

28-05-2025

EJNMMI research

Metabolic parameters on baseline and early [¹⁸F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.

28-05-2025

Physics in medicine and biology

Dose adaptation to compensate for cumulative intra-fraction motion effects in online adaptive radiotherapy.

27-05-2025

Journal of cancer survivorship : research and practice

Return to work after neoadjuvant versus adjuvant immunotherapy in stage III melanoma patients.

26-05-2025

Nature communications

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

25-05-2025

Journal of experimental & clinical cancer research : CR

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS).

23-05-2025

Translational psychiatry

Psychiatric and cognitive function in patients with serotonin producing neuroendocrine tumors.

21-05-2025

Proceedings of the National Academy of Sciences of the United States of America

Reply to Mishima et al.: MALT1 modulates GPX4 expression by regulating its stability.

20-05-2025

BJU international

Robot-assisted PSMA-radioguided surgery for local recurrence in the prostatic bed.

19-05-2025

Developmental cell

DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma.

19-05-2025

Scientific reports

Real-time peri-operative microcalcification detection in superficial breast tissues.

16-05-2025

Studies in health technology and informatics

From Federated Learning to Publicly Facing Platform; Proof-of-Concept of the STRONG AYA Information Portal.

15-05-2025

NPJ precision oncology

Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers.

14-05-2025

Blood advances

Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation.

13-05-2025

bioRxiv : the preprint server for biology

A functionally validated TCR-pMHC database for TCR specificity model development.

12-05-2025

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.

10-05-2025

Genome biology

Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterations.

09-05-2025

Research square

Disentangling the Complex Relationships Between Autoimmune Diseases and Cancer Through Polygenic Risk Scores: Evidence from a Large Prospective Study.

07-05-2025

Developmental cell

Stemness in flux: Dissecting intestinal crypt organization with multimodal approaches.

05-05-2025

European journal of cancer (Oxford, England : 1990)

Added prognostic value of circulating tumor cell numbers in CSF of patients with leptomeningeal metastasis from epithelial tumors.

02-05-2025

European journal of cancer (Oxford, England : 1990)

Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study.

02-05-2025

European journal of cancer (Oxford, England : 1990)

Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategy.

02-05-2025

European journal of cancer (Oxford, England : 1990)

Guidance for discussants of randomized cancer trials at major meetings.

02-05-2025

Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma.

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development.

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).

Detecting ribosome collisions with differential rRNA fragment analysis in ribosome profiling data.

Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient-A Case Report.

Cancer risk after in utero exposure to diethylstilbestrol.

Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues.

General Practitioners' Experiences With Implementing Colon or Prostate Cancer Survivorship Care in Primary Care: A Cross-Sectional Survey Nested Within Two Randomized-Controlled Trials.

Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype.

Myeloid cell path to malignancy: insights into liver cancer.

Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.

Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.

No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO).

Muscle atrophy and organ enlargement associated with quality of life during systemic therapy for melanoma: findings from an AI-based body composition analysis.

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.

Reply.

The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma.

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.

Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

Strategies to reduce the cancer burden and improve access to effective and affordable cancer interventions in Europe.

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study.

Can't I continue to exercise here? Exploring experiences, barriers, and facilitators for physical therapists and survivors of cancer to promote exercise maintenance.

Metabolic parameters on baseline and early [18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.

Dose adaptation to compensate for cumulative intra-fraction motion effects in online adaptive radiotherapy.

Return to work after neoadjuvant versus adjuvant immunotherapy in stage III melanoma patients.

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS).

Psychiatric and cognitive function in patients with serotonin producing neuroendocrine tumors.

Reply to Mishima et al.: MALT1 modulates GPX4 expression by regulating its stability.

Robot-assisted PSMA-radioguided surgery for local recurrence in the prostatic bed.

DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma.

Real-time peri-operative microcalcification detection in superficial breast tissues.

From Federated Learning to Publicly Facing Platform; Proof-of-Concept of the STRONG AYA Information Portal.

Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers.

Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation.

A functionally validated TCR-pMHC database for TCR specificity model development.

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.

Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterations.

Disentangling the Complex Relationships Between Autoimmune Diseases and Cancer Through Polygenic Risk Scores: Evidence from a Large Prospective Study.

Stemness in flux: Dissecting intestinal crypt organization with multimodal approaches.

Added prognostic value of circulating tumor cell numbers in CSF of patients with leptomeningeal metastasis from epithelial tumors.

Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study.

Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategy.

Guidance for discussants of randomized cancer trials at major meetings.

This site uses cookies

Metabolic parameters on baseline and early [¹⁸F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.